Parkinson's Disease Patient Characteristics in a US Real-World Study of Opicapone

被引：0
|
作者：
LeWitt, Peter A. [1 ]
Klepitskaya, Olga [2 ]
Serbin, Michael [2 ]
Jen, Eric [2 ]
Rattana, Stacy K. [3 ]
Trotter, Jeff [3 ]
Liang, Grace S. [2 ]
机构：
[1] Wayne State Univ Sch Med, Detroit, MI USA
[2] Neurocrine Biosci Inc, San Diego, CA USA
[3] Worldwide Clin Trials, Res Triangle Pk, Res Triangle Pk, NC USA
来源：
ANNALS OF NEUROLOGY | 2022年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
M193
引用
收藏
页码：S119 / S120
页数：2
相关论文
共 50 条
  • [1] Influence of disease duration in the Opicapone effectiveness in Parkinson's patients: real-world OPTIPARK study
    Warnecke, T.
    Reichmann, H.
    Lees, A.
    Marinho, D.
    Magalhaes, D.
    Rocha, J. F.
    Soares-da-Silva, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 904 - 904
  • [2] Opicapone in Parkinson's Disease: Real-World Data from a Portuguese Center
    Meira-Carvalho, Filipa
    Da Silva, Jorge Diogo
    Rodrigues, Margarida
    [J]. EUROPEAN NEUROLOGY, 2021, 84 (02) : 129 - 131
  • [3] OPTI-ON: A Longitudinal Real-World Study of Opicapone in Patients with Parkinson's disease and Motor Fluctuations
    LeWitt, P.
    Klepitskaya, O.
    Bahroo, L.
    Liang, G.
    Rattana, S.
    Trotter, J.
    Serbin, M.
    [J]. MOVEMENT DISORDERS, 2021, 36 : S182 - S183
  • [4] OPTI-ON: A Longitudinal Real-World Study of Opicapone in Patients with Parkinson's Disease and Motor Fluctuations
    LeWitt, Peter
    Klepitskaya, Olga
    Bahroo, Laxman B.
    Liang, Grace S.
    Rattana, Stacy
    Trotter, Jeffrey
    Serbin, Michael
    [J]. ANNALS OF NEUROLOGY, 2021, 90 : S148 - S148
  • [5] Influence of demographic characteristics on the effectiveness of opicapone in Parkinson's disease patients with motor fluctuations: Findings from the real-world OPTIPARK study
    Mohamed, Biju
    Lees, Andrew
    Reichmann, Heinz
    Martins, Diogo
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 271 - 272
  • [6] Influence of demographic characteristics on the effectiveness of opicapone in Parkinson's disease patients with motor fluctuations: findings from the real-world OPTIPARK study
    Mohamed, B.
    Lees, A.
    Reichmann, H.
    Martins, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    [J]. MOVEMENT DISORDERS, 2021, 36 : S223 - S223
  • [7] Effectiveness of Opicapone in Parkinson's according to baseline use of safinamide: the real-world OPTIPARK study
    Pavese, N.
    Lees, A.
    Reichmann, H.
    Martins, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 321 - 321
  • [8] Influence of onset of motor fluctuations in the Opicapone effectiveness in Parkinson's: real-world OPTIPARK study
    Jost, W.
    Reichmann, H.
    Lees, A.
    Marinho, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 382 - 382
  • [9] Effectiveness of Opicapone in Parkinson's according to baseline use of entacapone: the real-world OPTIPARK study
    Jost, W.
    Reichmann, H.
    Lees, A.
    Marinho, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 383 - 383
  • [10] Influence of levodopa daily dose in Opicapone effectiveness in Parkinson's: the real-world OPTIPARK study
    Carroll, C.
    Lees, A.
    Reichmann, H.
    Martins, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 275 - 275
12345